SCHEMBL6033155

SCHEMBL6033155

c1ccc2c(NCCCCCCNc3c4ccccc4nc4ccccc34)c3ccccc3nc2c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 4/20 0.77
RAD52 P43351 4/20 0.77
RAB9A P51151 2/20 0.70
KDM4E B2RXH2 1/20 0.70
MITF O75030 1/20 0.70
ALDH1A1 P00352 1/20 0.70
LMNA P02545 1/20 0.70
TTR P02766 1/20 0.70
GLA P06280 1/20 0.70
GAA P10253 1/20 0.70
SLC2A1 P11166 3/20 0.70
KMT2A Q03164 2/20 0.70
NPC1 O15118 1/20 0.70
APOBEC3A P31941 1/20 0.70
APOBEC3G Q9HC16 1/20 0.70
CACNA2D1 P54289 1/20 0.69
BCHE P06276 9/20 0.62
ACHE P22303 8/20 0.62
HRH3 Q9Y5N1 1/20 0.62
GABRP O00591 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13856923 1.00 POLB (0.77) POLBRAD52RAB9AKDM4EMITF
SCHEMBL5578493 0.98 POLB (0.79) POLBRAD52RAB9AKDM4EMITF
Hydrochloric Acid SCHEMBL18334834 0.96 POLB (0.72) POLBRAD52RAB9AKDM4EMITF
SCHEMBL7869214 0.94 POLB (0.79) POLBRAD52RAB9AKDM4EMITF
SCHEMBL9415866 0.91 SLC2A1 (0.75) POLBRAD52RAB9AKDM4EMITF
SCHEMBL15867120 0.91 POLB (0.87) POLBRAD52RAB9AKDM4EMITF
SCHEMBL11934972 0.91 ACHE (0.67) POLBRAD52RAB9AKDM4EMITF
SCHEMBL8213149 0.91 POLB (0.70) POLBRAD52RAB9AKDM4EMITF
Hydrochloric Acid SCHEMBL8651166 0.90 SLC2A1 (0.78) POLBRAD52RAB9AKDM4EMITF
Hydrochloric Acid SCHEMBL8065778 0.90 ACHE (0.65) POLBRAD52RAB9AKDM4EMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024189607-A1 METHODS AND BIOAVAILABLE HIGHLY PERMEABLE COMPOUNDS FOR DISEASES TREATMENT DIDENKO KIRILL (MX) 2024-09-19 WO disclosed
US-7144738-B2 Materials for enhancing staining of biopolymers in matrices WHITNEY SCOTT 2006-12-05 US disclosed
US-20050170517-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION (US) 2005-08-04 US disclosed
US-6878551-B2 For proteins/polypeptides within polyacrylamide matrix; mass spectrometry INVITROGEN CORPORATION (US) 2005-04-12 US disclosed
US-20040038418-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION 2004-02-26 US disclosed
US-6635489-B2 Sensitizing the matrix with heteroaromatic compounds, contacting with reduceable metal salts to stain and detecting INVITROGEN CORPORATION 2003-10-21 US disclosed
US-20020137222-A1 Materials for enhancing staining of biopolymers in matrices INVITROGEN CORPORATION 2002-09-26 US disclosed
US-4812449-A SYNTHESIS AT TARGET SITES, MICROENVIRONMENT SCRIPPS CLINIC AND RESEARCH FOUNDATION (US) 1989-03-14 US disclosed
EP-0175371-A2 Method for silver staining proteins and nucleic acids E.I. DU PONT DE NEMOURS AND COMPANY (US) 1986-03-26 EP disclosed
US-4575452-A Kit for silver staining proteins and nucleic acids E. I. DU PONT DE NEMOURS AND COMPANY (US) 1986-03-11 US disclosed